$nktr
Nektar Therapeutics (NKTR) sees a surge in social media mentions and creator activity, driven by positive clinical data and stock performance, while ongoing legal battles with Eli Lilly (LLY) create uncertainty.
About $nktr
Nektar Therapeutics is a biotechnology company focused on developing innovative therapies.
Insights
- $nktr mentions hit [---] which is 158% higher than it's daily average.
- $nktr creators is up 612.82% from the previous month.
- $nktr engagements is up 1767.12% from the previous week.
- $nktr mentions is up 1036% from the previous month.
- $nktr posts created is up 525% from the previous week.
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +1,767%
[--] Month: [---------] -0.39%
[--] Months: [----------] +48%
[--] Year: [----------] +1,868%
1-Year High: [---------] on 2025-06-24
1-Year Low: [---] on 2025-04-08
Engagements by network (24h): X: [------] Reddit: [--] YouTube: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +402%
[--] Month: [---] +1,036%
1-Year High: [-----] on 2025-06-25
1-Year Low: [--] on 2025-05-27
Mentions by network (24h): X: [---] Reddit: [--] YouTube: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning $nktr in the last [--] hours which is up 23% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] +320%
[--] Month: [---] +613%
1-Year High: [-----] on 2025-06-25
1-Year Low: [--] on 2025-05-24
The most influential creators that mention $nktr in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @financebully | [--] | [-----] | [--] | [------] |
| @tradingsssss | [--] | [-----] | [--] | [-----] |
| @A_May_MD | [--] | [------] | [--] | [-----] |
| @semodough | [--] | [------] | [--] | [-----] |
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
| @Taintslapp12283 | [--] | [---] | [--] | [-----] |
| @HOThomasWPhelps | [--] | [-----] | [--] | [-----] |
| @BlueWinterMgmt | [--] | [---] | [--] | [-----] |
| @DSAkdag | [--] | [------] | [--] | [-----] |
| @InfoBreakout | [--] | [---] | [--] | [-----] |
Sentiment: 78%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 78%
Daily Average: 81%
[--] Week: 89% -11%
[--] Month: 83% +34%
[--] Months: 83% -3%
[--] Year: 83% -17%
1-Year High: 100% on 2025-02-17
1-Year Low: 33% on 2025-03-31
Most Supportive Themes:
- Positive Stock Performance and Analyst Confidence: (40%) Multiple posts highlight Nektar's (NKTR) recent stock performance, with some noting significant gains since previous pitches. Analysts express confidence in the company's valuation and future potential, even comparing it favorably to competitors.
- Clinical Data and Pipeline Potential: (30%) Discussions revolve around Nektar's clinical data, particularly in dermatology, with comparisons to competitor drugs like Dupixent. The potential for dual indications and efficient P3 studies is seen as a significant tailwind.
- Strategic Moves and Executive Changes: (20%) Posts mention Nektar's ongoing legal situations and recent executive changes, such as the Chief Legal Officer's departure and subsequent move to Septerna. These events are noted in the context of the company's broader strategic landscape.
Most Critical Themes:
- Legal Battles and Uncertainty: (70%) Nektar's legal proceedings, particularly with Eli Lilly (LLY), are a recurring theme, creating an undercurrent of uncertainty. The resolution of these cases is seen as a key factor influencing the stock's trajectory.
- Competitive Landscape and Alternative Investments: (30%) Some posts suggest alternative investment opportunities or compare Nektar unfavorably to competitors, indicating that the market may be overlooking other promising biotech plays. This highlights the competitive nature of the sector.
Top $nktr Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Liquid stocks that made new highs on Friday & doubled over the last [--] weeks: $ANAB $ECG $FORM $FSLY $GTX $NKTR $SEI $SPHR $VAL"
X Link @NickDrendel 2026-02-16T00:41Z 19.9K followers, [----] engagements
"Note to self. DO NOT BUY $ocul Tuesday PM Just buy more $nktr and $ABVX and steadily become richer over the next few months. May sneak a few shares $ocul tho"
X Link @Taintslapp12283 2026-02-15T23:32Z [---] followers, [----] engagements
"Adam thank you for your insights.you are truly a great member of the community. We got to $NKTR early as a member of our network our Wolfpack as we like to say tipped us off at $9.50/share and have scaled up. We are building the best network of research OFF of Wall Street after a 20+ year career at the Big Banks as a PM and a great track record.we are looking forward to more. Come subscribe for free.advisorsedge.substack.com http://we.ve $NKTR bears will still look at you with a straight face and tell you that an adverse event (ISRs) that led to a LESS THAN 1% discontinuation rate is"
X Link @AdvisorsEdge 2026-02-15T22:36Z [---] followers, [---] engagements
"Haftalk portfy update Deimeyenler: $pali $ovid $abvx $ivvd $alxo $avxl $artv $oric $eldn $plx $pasg $tenx $sgmt $irwd $orgo Kapananlar: $nktr (+%94) Azalanlar: Artanlar : Yeni eklenenler: [--] haftalk aradan sonra ofise dnyorum. Dnmeye ok da can attm sylenemez 🫣😅 Nktr hala gidecek yeri olduunu dnmeme ramen ok hzl gitti diye kapatasm geldi. Tamamen gut feeling. geri dneceim XBI taraf patinaj ekmeye balad. Hala reverse bir etf de long olmadm. Aklmda $labd var x3 bio bear. Hedge iin ideal Sgmt de pozisyon arttrm iin aa ya da yukar sert bir mum bekliyorum. Irwd sabah bi arkada mesaj atm ayn"
X Link @DSAkdag 2026-02-15T19:11Z 10.8K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing